Cabaletta Bio (CABA) Accumulated Depreciation (2019 - 2025)

Cabaletta Bio's Accumulated Depreciation history runs 7 years deep, the most recent figure standing at $7.2 million for Q4 2025.

• On a quarterly basis, Accumulated Depreciation rose 29.89% year-over-year to $7.2 million in Q4 2025; TTM through Dec 2025 was $7.2 million, a 29.89% increase from a year earlier, with the FY2025 full-year figure at $7.2 million, up 29.89% from the prior year.
• Accumulated Depreciation advanced to $7.2 million in Q4 2025 per CABA's latest filing, from $5.5 million in the prior quarter.
• Across five years, Accumulated Depreciation topped out at $7.2 million in Q4 2025 and bottomed at $1.2 million in Q4 2021.
• The 5-year median for Accumulated Depreciation is $3.8 million (2023), against an average of $4.0 million.
• Across the five-year window, Accumulated Depreciation jumped 160.04% in 2021 and advanced 29.89% in 2025, its largest moves.
• Year by year, Accumulated Depreciation stood at $1.2 million in 2021, then surged by 98.91% to $2.4 million in 2022, then soared by 60.19% to $3.8 million in 2023, then soared by 45.09% to $5.5 million in 2024, then rose by 29.89% to $7.2 million in 2025.
• Per Business Quant, the three latest CABA Accumulated Depreciation figures stand at $7.2 million (Q4 2025), $5.5 million (Q4 2024), and $3.8 million (Q4 2023).